Overview

Vaccine Administration Devices Market Overview:

A vaccination is a chemical that is injected into the body to prevent infection or disease caused by a pathogen, such as a virus, bacteria, or parasite. By triggering an immunological reaction, the vaccine instructs the body on how to defend itself against the disease. Preventive vaccinations operate by delivering a small component or a non-harmful form of the pathogen (known as the foreign antigen) into the body, which protects the individual from infection or sickness. Antibodies (through the humoral reaction), killer cells (by the cell mediated response), or both are produced in the body in response to the pathogen. Inactivated/killed vaccinations, live/attenuated vaccines, toxoid vaccines, and conjugate vaccines are examples of vaccine types. Using a syringe or needle, vaccines are delivered intramuscularly or subcutaneously. Vaccine administration devices include features such as the development of novel vaccines, which will have an impact on manufacturers launching new products into the market, increasing demand, as well as the rising burden of infectious diseases, which leads to the demand for precise vaccine administration in order to elicit a strong immune response on delivery of targeted vaccines. Various research studies are now being conducted, which are likely to give producers with a competitive advantage in developing new and novel vaccine administration devices, as well as other opportunities in the vaccine administration devices market. The vaccine administration devices market is likely to be restrained in the forecast period due to the difficulty of mucosal delivery of vaccinations and patients' phobia of injections and needle sticks.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Vaccine Administration Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Vaccine Administration Devices Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Vaccine Administration Devices Market:
• BD
• Terumo Europe Nv (A Subsidiary Of Terumo Corporation)
• Gerresheimer AG
• West Pharmaceutical Services, Inc.
• Schott Ag (A Subsidiary Of Carl-zeiss-stiftung)
• 3M
• Antares Pharma
• Bespak Europe Ltd.
• Corium Inc.
• D'antonio Consultants International, Inc.
• Enesi
• Ihealthnet Llc.
• Injex Uk
• Inovio Pharmaceuticals
• Medical International Technologies (Mit Canada) Inc.
• Micropoint Technolgies
• Mylan Pharmaceuticals Inc. (A Subsidiary Of Mylan N.V.)
• Mystic Pharmaceuticals
• Nanopass
• Pharmajet
• Star Syringe Limited
• Vaxxas Pty. Ltd.
(Note: The list of the major players will be updated with the latest market scenario and trends)

Vaccine Administration Devices Market Segmentation:
By Product
• Auto Injector
 o Intramuscular
 o Subcutaneous
• Jet Injectors
 o Disposable Cartridge Jet Injector (Dcji) With Prefilled Unit Dose Cartridges
 o Single-use Disposable Jet Injectors (Sudji)
 o Disposable Cartridge Jet Injectors (Dcji): End-user Filling.
 o Solid Particle Jet Injectors
• Micro Needles
 o Hollow Microneedles
 o Vaccine -coated Microneedles
 o Dissolvable/biodegradable Microneedles
 o Solid Microneedles
• Inhalation/pulmonary Delivery
 o Powder Inhalation
 o Liquid Inhalation
• Microinjection Systems
• Pen-injector Devices
• Biodegradable Implants
• Electroporation-based Needle Free Injection Systems
• Buccal / Sublingual Vaccine Delivery Systems
• Auto-injector Trainer Devices
• Other Devices
By Route of Administration
• Intramuscular Vaccination
• Subcutaneous Vaccination
• Intradermal Vaccination
By Type
• Marketed- Vaccines
 o Syringes
 o Autoinjectors
   • Intramuscular
   • Subcutaneuos
 o Jet Injectors
 o Microneedles
 o Aerosol/dry Powder Inhalation
 o Microinjection System
 o Biodegradable Implants
 o Electroporation- Based Needle Free Injection Systems
 o Buccal /sublingual Vaccine Delivery Systems
 o Others Devices
• Clinical- Stage Vaccines
By Brand
• Bd Accuspray Nasal Spray System
• Bd Hypak For Vaccines Glass Pre-fillable Syringe System
• Bd Uniject Auto-disable Pre-fillable Injection System
• Plajex
• Gx Rtf Clearject
• Gx Innosafe
• Others
By Vaccine Type
• Bivalent Oral Polio Vaccine
• Bcg Vaccine
• Tetanus-diphtheria Vaccine
• Dtp-hepb-hib Vaccine
• Influenza Vaccine
• Pneumococcal Conjugate Vaccine
• Measles Vaccine
• Others
By Modality
• Automatic Vaccine Administration Device
• Manual Vaccine Administration Device
By Usability
• Disposable
• Reusable
By End User
• Hospitals
• Community Centers
• Homecare Setting
• Research And Academic Institutes
• Ambulatory Surgical Center
• Others
By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Vaccine Administration Devices Market By Product, By Route of Administration, By Type, By Brand, By Vaccine Type, By Modality, By Usability, By End User, and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
  1.1 Objectives of the Study
  1.2 Market Definition
  1.3 Market Scope
      1.3.1 Years Considered for the Study
      1.3.2 Market Covered
  1.4 Currency
  1.5 Limitations
  1.6 Stakeholders

2. Research Methodology
  2.1 Research Data
      2.1.1 Secondary Data
            2.1.1.1 Key Data from Secondary Sources
      2.1.2 Primary Data
            2.1.2.1 Key Data from Primary Sources
  2.2 Market Size Estimation
  2.3 Market Breakdown and Data Triangulation
  2.4 Assumptions for the Study  

3. Executive Summary
  3.1 Market Outlook
  3.2 Segment Outlook
  3.3 Competitive Insights

4. Vaccine Administration Devices Market Variables, Trends & Scope
  4.1. Market Lineage Outlook
  4.2. Penetration and Growth Prospect Mapping
  4.3. Industry Value Chain Analysis
  4.4. Cost Analysis Breakdown
  4.5. Technology Overview
  4.6. Regulatory Framework
       4.6.1. Reimbursement Framework
       4.6.2. Standards and Compliances

5. Market Overview
  5.1. Market Dynamics
       5.1.1. Market Driver Analysis
              5.1.1.1. Increasing focus of Vaccine Administration Devices Market Companies on Brand Protection
              5.1.1.2. Untapped Opportunities in Emerging Regions
       5.1.2. Market Restraint Analysis
              5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
       5.1.3. Industry Challenges
              5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Vaccine Administration Devices Market Analysis Tools
  6.1. Industry Analysis - Porter’s
       6.1.1. Supplier Power
       6.1.2. Buyer Power
       6.1.3. Substitution Threat
       6.1.4. Threat from New Entrants
       6.1.5. Competitive Rivalry
  6.2. Pestel Analysis
       6.2.1. Political Landscape
       6.2.2. Environmental Landscape
       6.2.3. Social Landscape
       6.2.4. Technology Landscape
       6.2.5. Legal Landscape
  6.3. Major Deals And Strategic Alliances Analysis
       6.3.1. Joint Ventures
       6.3.2. Mergers and Acquisitions
       6.3.3. Licensing and Partnership
       6.3.4. Technology Collaborations
       6.3.5. Strategic Divestments
  6.4. Market Entry Strategies
  6.5. Case Studies

7. Vaccine Administration Devices Market, By Product Historical Analysis and Forecast 2022-2028 (USD Million)
  7.1. Auto Injector
       7.1.1. Intramuscular
       7.1.2. Subcutaneous
  7.2. Jet Injectors
       7.2.1. Disposable Cartridge Jet Injector (Dcji) With Prefilled Unit Dose Cartridges
       7.2.2. Single-use Disposable Jet Injectors (Sudji)
       7.2.3. Disposable Cartridge Jet Injectors (Dcji): End-user Filling.
       7.2.4. Solid Particle Jet Injectors
  7.3. Micro Needles
       7.3.1. Hollow Microneedles
       7.3.2. Vaccine -coated Microneedles
       7.3.3. Dissolvable/biodegradable Microneedles
       7.3.4. Solid Microneedles
  7.4. Inhalation/pulmonary Delivery
       7.4.1. Powder Inhalation
       7.4.2. Liquid Inhalation
  7.5. Microinjection Systems
  7.6. Pen-injector Devices
  7.7. Biodegradable Implants
  7.8. Electroporation-based Needle Free Injection Systems
  7.9. Buccal / Sublingual Vaccine Delivery Systems
  7.10.Auto-injector Trainer Devices
  7.11.Other Devices

8. Vaccine Administration Devices Market, By Route of Administration Historical Analysis and Forecast 2022-2028 (USD Million)  
  8.1. Intramuscular Vaccination
  8.2. Subcutaneous Vaccination
  8.3. Intradermal Vaccination

9. Vaccine Administration Devices Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million)  
  9.1. Marketed- Vaccines
       9.1.1. Syringes
       9.1.2. Autoinjectors
              9.1.2.1. Intramuscular
              9.1.2.2. Subcutaneuos
       9.1.3. Jet Injectors
       9.1.4. Microneedles
       9.1.5. Aerosol/dry Powder Inhalation
       9.1.6. Microinjection System
       9.1.7. Biodegradable Implants
       9.1.8. Electroporation- Based Needle Free Injection Systems
       9.1.9. Buccal /sublingual Vaccine Delivery Systems
       9.1.10.Others Devices
  9.2. Clinical- Stage Vaccines

10. Vaccine Administration Devices Market, By Brand Historical Analysis and Forecast 2022-2028 (USD Million)  
   10.1. Bd Accuspray Nasal Spray System
   10.2. Bd Hypak For Vaccines Glass Pre-fillable Syringe System
   10.3. Bd Uniject Auto-disable Pre-fillable Injection System
   10.4. Plajex
   10.5. Gx Rtf Clearject
   10.6. Gx Innosafe
   10.7. Others
 
11. Vaccine Administration Devices Market, By Vaccine Type Historical Analysis and Forecast 2022-2028 (USD Million)  
   11.1. Bivalent Oral Polio Vaccine
   11.2. Bcg Vaccine
   11.3. Tetanus-diphtheria Vaccine
   11.4. Dtp-hepb-hib Vaccine
   11.5. Influenza Vaccine
   11.6. Pneumococcal Conjugate Vaccine
   11.7. Measles Vaccine
   11.8. Others

12. Vaccine Administration Devices Market, By Modality Historical Analysis and Forecast 2022-2028 (USD Million)  
   12.1. Automatic Vaccine Administration Device
   12.2. Manual Vaccine Administration Device

13. Vaccine Administration Devices Market, By Usability Historical Analysis and Forecast 2022-2028 (USD Million)  
   13.1. Disposable
   13.2. Reusable

14. Vaccine Administration Devices Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million)
   14.1. Hospitals
   14.2. Community Centers
   14.3. Homecare Setting
   14.4. Research And Academic Institutes
   14.5. Ambulatory Surgical Center
   14.6. Others  

15. North America Vaccine Administration Devices Market Analysis 2117-2121 and Forecast 2123-2128 (USD Million)
   15.1. Introduction
   15.2. Historical Market Size (USD Million) Analysis By Country, 2117-2121
         15.2.1. U.S.A
         15.2.2. Canada
         15.2.3. Mexico
   15.3. Market Size (USD Million) Forecast for North America 2123-2128

16. Latin America Vaccine Administration Devices Market Analysis 2117-2121 and Forecast 2123-2128 (USD Million)
   16.1. Introduction
   16.2. Historical Market Size (USD Million) Analysis By Country, 2117-2121
         16.2.1. Brazil
         16.2.2. Venezuela
         16.2.3. Argentina
         16.2.4. Rest of Latin America
   16.3. Market Size (USD Million) Forecast for Latin America 2123-2128

17. Europe Vaccine Administration Devices Market Analysis 2117-2121 and Forecast 2123-2128 (USD Million)
   17.1. Introduction
   17.2. Historical Market Size (USD Million) Analysis By Country, 2117-2121
         17.2.1. Germany
         17.2.2. U.K        
         17.2.3. France
         17.2.4. Italy
         17.2.5. Spain
         17.2.6. Russia
         17.2.7. Poland
         17.2.8. Rest of Europe
   17.3. Market Size (USD Million) Forecast for Europe 2123-2128

18. Asia Pacific Vaccine Administration Devices Market Analysis 2117-2121 and Forecast 2123-2128 (USD Million)
   18.1. Introduction
   18.2. Historical Market Size (USD Million) Analysis By Country, 2117-2121
         18.2.1. Japan
         18.2.2. China
         18.2.3. India
         18.2.4. Australia and New Zealand
         18.2.5. ASEAN
         18.2.6. Rest of Asia Pacific
   18.3. Market Size (USD Million) Forecast for Asia Pacific 2123-2128  

19. Middle East and Africa Market Analysis 2117-2121 and Forecast 2123-2128 (USD Million)
   19.1. Introduction
   19.2. Historical Market Size (USD Million) Analysis By Country, 2117-2121
         19.2.1. GCC
         19.2.2. Israel
         19.2.3. South Africa
         19.2.4. Rest of MEA
   19.3. Market Size (USD Million) Forecast for MEA 2123-2128

20. Market Share Analysis and Competitive Landscape  
   20.1. Global Landscape - Key Players, Revenue and Presence
   20.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
   20.3. Global Emerging Companies
   20.4. North America - Market Share Analysis and Key Regional Players
   20.5. Europe - Market Share Analysis and Key Regional Players
   20.6. Asia Pacific - Market Share Analysis and Key Regional Players
   20.7. Global Key Player - Growth Matrix

21. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
   21.1. BD
         21.1.1. Company Overview
         21.1.2. Product Portfolio
         21.1.3. SWOT Analysis
         21.1.4. Financial Overview
         21.1.5. Strategic Overview
   21.2. Terumo Europe Nv (A Subsidiary Of Terumo Corporation)
         21.2.1. Company Overview
         21.2.2. Product Portfolio
         21.2.3. SWOT Analysis
         21.2.4. Financial Overview
         21.2.5. Strategic Overview
   21.3. Gerresheimer AG
         21.3.1. Company Overview
         21.3.2. Product Portfolio
         21.3.3. SWOT Analysis
         21.3.4. Financial Overview
         21.3.5. Strategic Overview
   21.4. West Pharmaceutical Services, Inc.
         21.4.1. Company Overview
         21.4.2. Product Portfolio
         21.4.3. SWOT Analysis
         21.4.4. Financial Overview
         21.4.5. Strategic Overview
   21.5. Schott Ag (A Subsidiary Of Carl-zeiss-stiftung)
         21.5.1. Company Overview
         21.5.2. Product Portfolio
         21.5.3. SWOT Analysis
         21.5.4. Financial Overview
         21.5.5. Strategic Overview          
   21.6. 3M
         21.6.1. Company Overview
         21.6.2. Product Portfolio
         21.6.3. SWOT Analysis
         21.6.4. Financial Overview
         21.6.5. Strategic Overview      
   21.7. Antares Pharma
         21.7.1. Company Overview
         21.7.2. Product Portfolio
         21.7.3. SWOT Analysis
         21.7.4. Financial Overview
         21.7.5. Strategic Overview
   21.8. Bespak Europe Ltd.
         21.8.1. Company Overview
         21.8.2. Product Portfolio
         21.8.3. SWOT Analysis
         21.8.4. Financial Overview
         21.8.5. Strategic Overview
   21.9. Corium Inc.
         21.9.1. Company Overview
         21.9.2. Product Portfolio
         21.9.3. SWOT Analysis
         21.9.4. Financial Overview
         21.9.5. Strategic Overview
   21.10.D'antonio Consultants International, Inc.
         21.10.1. Company Overview
         21.10.2. Product Portfolio
         21.10.3. SWOT Analysis
         21.10.4. Financial Overview
         21.10.5. Strategic Overview
   21.11.Enesi
         21.11.1. Company Overview
         21.11.2. Product Portfolio
         21.11.3. SWOT Analysis
         21.11.4. Financial Overview
         21.11.5. Strategic Overview
   21.12.Ihealthnet Llc.
         21.12.1. Company Overview
         21.12.2. Product Portfolio
         21.12.3. SWOT Analysis
         21.12.4. Financial Overview
         21.12.5. Strategic Overview
   21.13.Injex Uk
         21.13.1. Company Overview
         21.13.2. Product Portfolio
         21.13.3. SWOT Analysis
         21.13.4. Financial Overview
         21.13.5. Strategic Overview
  20.14.Inovio Pharmaceuticals
         20.14.1. Company Overview
         20.14.2. Product Portfolio
         20.14.3. SWOT Analysis
         20.14.4. Financial Overview
         20.14.5. Strategic Overview
   20.15.Medical International Technologies (Mit Canada) Inc.
         20.15.1. Company Overview
         20.15.2. Product Portfolio
         20.15.3. SWOT Analysis
         20.15.4. Financial Overview
         20.15.5. Strategic Overview          
   20.16.Micropoint Technolgies
         20.16.1. Company Overview
         20.16.2. Product Portfolio
         20.16.3. SWOT Analysis
         20.16.4. Financial Overview
         20.16.5. Strategic Overview      
   20.17.Mylan Pharmaceuticals Inc. (A Subsidiary Of Mylan N.V.)
         20.17.1. Company Overview
         20.17.2. Product Portfolio
         20.17.3. SWOT Analysis
         20.17.4. Financial Overview
         20.17.5. Strategic Overview
   20.18.Mystic Pharmaceuticals
         20.18.1. Company Overview
         20.18.2. Product Portfolio
         20.18.3. SWOT Analysis
         20.18.4. Financial Overview
         20.18.5. Strategic Overview
   20.19.Nanopass
         20.19.1. Company Overview
         20.19.2. Product Portfolio
         20.19.3. SWOT Analysis
         20.19.4. Financial Overview
         20.19.5. Strategic Overview
   20.20.Pharmajet
         20.20.1. Company Overview
         20.20.2. Product Portfolio
         20.20.3. SWOT Analysis
         20.20.4. Financial Overview
         20.20.5. Strategic Overview
   20.21.Star Syringe Limited
         20.21.1. Company Overview
         20.21.2. Product Portfolio
         20.21.3. SWOT Analysis
         20.21.4. Financial Overview
         20.21.5. Strategic Overview
   20.22.Vaxxas Pty. Ltd.
         20.22.1. Company Overview
         20.22.2. Product Portfolio
         20.22.3. SWOT Analysis
         20.22.4. Financial Overview
         20.22.5. Strategic Overview

22. Pre and Post COVID-20 Impact
   22.1. Positive influence on the healthcare industry
   22.2. The financial disruption of the manufacturing sector
   22.3. Impact of COVID-20 on emerging companies
   22.4. Significant mandates in the healthcare regulations initiated by administrations
   22.5. The overall economic slowdown of the developing and developed nations

23. FutureWise SME Key Takeaway Points for Client

Tables

Figures